Filing Details

Accession Number:
0001209191-19-028280
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 17:15:09
Reporting Period:
2019-05-07
Accepted Time:
2019-05-08 17:15:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS Pharmaceutical Preparations (2834) 264738379
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703723 Pascale Witz C/O Regulus Therapeutics Inc.
10628 Science Center Dr., #100
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-07 29,630 $1.08 37,849 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant (Right to Buy) Acquisiton 2019-05-07 29,630 $0.13 29,630 $1.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,630 2019-05-07 2024-05-07 No 4 P Direct